18.08.2026 • Sponsored • Topics

Modular Automation Moves from Vision to GMP Reality

A pharma project demonstrates how MTP can accelerate integration while reducing validation effort.

Pharmaceutical manufacturers need production facilities that can adapt quickly to new therapies, shorter product lifecycles, and fluctuating demand. Modular automation concepts address this need by making equipment easier to integrate, expand, and operate across flexible manufacturing environments.

A key enabler is the Module Type Package (MTP). It standardizes the integration of process equipment into higher-level automation systems through defined services and interfaces. This creates the basis for plug-and-produce scenarios in which modules from different suppliers can be connected more rapidly within a common orchestration framework.

For pharmaceutical production, the benefits are substantial: simplified plant expansion, consistent user interfaces, standardized links to MES or historian systems, and reduced engineering dependencies between individual systems.

The ZETA FreezeController was developed as an MTP-ready Process Equipment...
The ZETA FreezeController was developed as an MTP-ready Process Equipment Assembly enabling seamless integration into modular automation architectures.
© ZETA

Bridging the Gap Between Standards and Practice

In GMP-regulated environments, however, MTP implementation is still demanding. Evolving standards, adapted qualification concepts, and clearly defined responsibilities between vendors require close cooperation between automation suppliers, software providers, and end users.

A recent biopharmaceutical facility project shows how these challenges can be solved in practice. The project involved integrating a Freeze & Thaw unit into a new production environment based on a Process Orchestration Layer. The goal was to implement the system as an MTP-compliant Process Equipment Assembly (PEA) while ensuring GMP compliance and long-term scalability.

ZETA developed and implemented the automation solution, covering process engineering, software development, commissioning, and qualification support. The FreezeController was designed as a modular unit with a CODESYS-based control system, standardized MTP interfaces, OPC UA communication, and ISA S88-based process logic for batch-oriented manufacturing.

Collaboration as a Critical Success Factor

The project also highlighted the value of strong partner collaboration. Turck provided a validated GMP-compliant control and function block library, while COPA-DATA supported orchestration and MTP validation via zenon. Together, the partners translated an evolving standard into a robust, compliant architecture.

A decisive factor was the qualification strategy. Instead of validating a largely customized automation application, the team used standardized, prevalidated building blocks and tested the solution in advance within an orchestration environment. This supported classification as GAMP 5 Category 3 rather than Category 5, reducing qualification complexity and effort.

Measurable Benefits

The results were measurable. Module integration into the orchestration environment was completed in about one hour, while overall integration effort was reduced by up to 80%. Operators also gained a harmonized interface, simplifying training and daily operation.

The project demonstrates that MTP is moving from concept to GMP reality. With standardized automation components, a structured qualification approach, and close collaboration between technology partners, modular automation can improve project execution and operational flexibility in pharmaceutical manufacturing.

Company

Logo:

Zeta GmbH

Zetaplatz 1
8501 Graz/Lieboch
Austria

Company contact







Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read